White Paper
Bridging the Language Gap
Enhancing clinical trials with translation
Jan 21, 2026

Effective translation is essential to running faster, higher‑quality global clinical trials. Poorly executed language solutions can delay studies, increase costs, and introduce risk. But when built with the right clinical expertise and technology, translation becomes a strategic driver of patient engagement, regulatory readiness, and R&D acceleration.

This IQVIA white paper, developed in conjunction with Fierce Pharma, highlights how sponsors can optimize study performance with specialized, industry‑specific language solutions.

Download it to learn more on:

  • How high‑quality, culturally accurate translations improve patient enrollment, comprehension, and retention
  • Why cultural adaptation, as opposed to literal translation, is critical for global study success
  • The value of partnering with clinical trial translation experts
  • Proven best practices to streamline workflows and reduce costly rework
  • How AI‑supported, industry‑trained translation enhances speed and quality safely

Related solutions

Contact Us